Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli

International Journal of Antimicrobial Agents

Volumn 35, Issue 4, 2010, Pages 333-337

  Takahata, Sho ^a   Ida, Takashi ^a   Hiraishi, Toru ^a   Sakakibara, Shiro ^a   Maebashi, Kazunori ^a   Terada, Shinichi ^a   Muratani, Tetsuro ^b   Matsumoto, Tetsuro ^b   Nakahama, Chikara ^c   Tomono, Kazunori ^d  

^a MEIJI SEIKA KAISHA LTD   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c Nakahama Clinic   (Japan)

^d OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Escherichia coli; Fosfomycin; GlpT; MurA; Resistance; UhpT

Indexed keywords

ASPARAGINE; BACTERIAL PROTEIN; FOSFOMYCIN; GLUCOSE 6 PHOSPHATE; GLYCEROPHOSPHATE; LEUCINE; PROTEIN CYAA; PROTEIN GLPT; PROTEIN MURA; PROTEIN PTSI; PROTEIN UHPA; PROTEIN UHPT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENZYME SUBSTRATE; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE INSERTION; GENE MUTATION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FOSFOMYCIN; HUMANS; INDEL MUTATION; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA;

EID: 76749133163     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.11.011     Document Type: Article

References (35)

1. Gupta K., Scholes D., and Stamm W.E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 281 (1999) 736-738
2. Naber K.G., Schito G., Botto H., Palou J., and Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol 54 (2008) 1164-1178
3. Muratani T., and Matsumoto T. Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae. Int J Antimicrob Agents 28 Suppl. 1 (2006) S10-S13
4. Stelling J.M., Travers K., Jones R.N., Turner P.J., O'Brien T.F., and Levy S.B. Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerg Infect Dis 11 (2005) 873-882
5. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., and Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 29 (1999) 745-758
6. Naber K.G., Bergman B., Bishop M.C., Bjerklund-Johansen T.E., Botto H., Lobel B., et al. EAU guidelines for the management of urinary and male genital tract infections. Eur Urol 40 (2001) 576-588
7. Kahan F.M., Kahan J.S., Cassidy P.J., and Kropp H. The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci 235 (1974) 364-386
8. Kadner R.J., and Winkler H.H. Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coli. J Bacteriol 113 (1973) 895-900
9. Nilsson A.I., Berg O.G., Aspevall O., Kahlmeter G., and Andersson D.I. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother 47 (2003) 2850-2858
10. Horii T., Kimura T., Sato K., Shibayama K., and Ohta M. Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coli O26. Antimicrob Agents Chemother 43 (1999) 789-793
11. Arca P., Rico M., Braña A.F., Villar C.J., Hardisson C., and Suárez J.E. Formation of an adduct between fosfomycin and glutathione: a new mechanism of antibiotic resistance in bacteria. Antimicrob Agents Chemother 32 (1988) 1552-1556
12. Cordaro J.C., Melton T., Stratis J.P., Atagün M., Gladding C., Hartman P.E., et al. Fosfomycin resistance: selection method for internal and extended deletions of the phosphoenolpyruvate:sugar phosphotransferase genes of Salmonella typhimurium. J Bacteriol 128 (1976) 785-793
13. Sakamoto Y., Furukawa S., Ogihara H., and Yamasaki M. Fosmidomycin resistance in adenylate cyclase deficient (cya) mutants of Escherichia coli. Biosci Biotechnol Biochem 67 (2003) 2030-2033
14. Shimizu M., Nonomiya T., Shigenobu F., O'Hara K., and Sawai T. Fosfomycin resistance in Escherichia coli in Japan. J Antibiot (Tokyo) 51 (1998) 889-892
15. Yoshida I., Fujimura T., Jinushi Y., Higashiyama I., Sugimori G., and Yamano Y. Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2002. Jpn J Chemother 54 (2006) 355-377 [in Japanese]
16. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 51 (2003) 69-76
17. Ishigami J., Ohbe S., Mita T., Miyazaki S., Akita Y., and Okunishi H. Clinical evaluation of fosfomycin for acute lower urinary tract infection: a double blind study. Acta Urol Jpn 21 (1975) 971-977 [in Japanese]
18. Fujita K., Narita K., Munakata A., and Murayama T. A clinical experience of fosfomycin tablet on cystitis. Jpn J Antibiot 41 (1988) 567-570 [in Japanese]
19. Minassian M.A., Lewis D.A., Chattopadhyay D., Bovill B., Duckworth G.J., and Williams J.D. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents 10 (1998) 39-47
20. Bonfiglio G., Mattina R., Lanzafame A., Cammarata E., and Tempera G. Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study. Chemotherapy 51 (2005) 162-166
21. Reeves D.S. Fosfomycin trometamol. J Antimicrob Chemother 34 (1994) 853-858
22. Blattner F.R., Plunkett III G., Bloch C.A., Perna N.T., Burland V., Riley M., et al. The complete genome sequence of Escherichia coli K-12. Science 277 (1997) 1453-1462
23. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2006.
24. Skarzynski T., Mistry A., Wonacott A., Hutchinson S.E., Kelly V.A., and Duncan K. Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin. Structure 4 (1996) 1465-1474
25. Yoon H.J., Lee S.J., Mikami B., Park H.J., Yoo J., and Suh S.W. Crystal structure of UDP-N-acetylglucosamine enolpyruvyl transferase from Haemophilus influenzae in complex with UDP-N-acetylglucosamine and fosfomycin. Proteins 71 (2008) 1032-1037
26. Kim D.H., Lees W.J., Kempsell K.E., Lane W.S., Duncan K., and Walsh C.T. Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. Biochemistry 35 (1996) 4923-4928
27. McCoy A.J., Sandlin R.C., and Maurelli A.T. In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance. J Bacteriol 185 (2003) 1218-1228
28. Huang Y., Lemieux M.J., Song J., Auer M., and Wang D.N. Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301 (2003) 616-620
29. Island M.D., Wei B.Y., and Kadner R.J. Structure and function of the uhp genes for the sugar phosphate transport system in Escherichia coli and Salmonella typhimurium. J Bacteriol 174 (1992) 2754-2762
30. Tsuruoka T., and Yamada Y. Characterization of spontaneous fosfomycin (phosphonomycin)-resistant cells of Escherichia coli B in vitro. J Antibiot (Tokyo) 28 (1975) 906-911
31. Kasai T., and Tsuruoka T. Pathogenicity of fosfomycin-resistant strains isolated from Escherichia coli. Jpn J Antibiot 52 (1999) 34-40 [in Japanese]
32. Galatti L., Sessa A., Mazzaglia G., Pecchioli S., Rossi A., Cricelli C., et al. Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study. J Antimicrob Chemother 57 (2006) 551-556
33. Gobernado M., Valdés L., Alós J.I., García-Rey C., Dal-Ré R., García-de-Lomas J., et al. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter 20 (2007) 68-76
34. Brown E.D., Vivas E.I., Walsh C.T., and Kolter R. MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in Escherichia coli. J Bacteriol 177 (1995) 4194-4197
35. Marchese A., Gualco L., Debbia E.A., Schito G.C., and Schito A.M. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance. Int J Antimicrob Agents 22 Suppl. 2 (2003) S53-S59